ArticleTherapeutic advances in pulmonary and critical care medicine
Point-of-Care Ultrasound as a Prognostic Tool in Critically Ill Patients: Insights Beyond Core Muscle Mass.
Article in Therapeutic advances in pulmonary and critical care medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Ultrasound- and circumference-based quadriceps mass is an independent predictor of 28-day mortality in critically ill patients.Frontiers in nutrition · 2026Article
- Dynamic changes in quadriceps and diaphragm thickness for early diagnosis of ICU-acquired weakness in elderly ICU patients: a prospective bedside ultrasound study.Frontiers in medicine · 2026Article
- Muscle matters: Transforming the care of intensive care unit acquired sarcopenia and myosteatosis.World journal of clinical cases · 2025Review
Corrections and comments
- Update of
Authors and funding
5 authors.
Funding
Abstract
Background: Muscle wasting is a critical and underrecognized determinant of outcomes in intensive care, yet conventional core muscle measurements such as computed tomography (CT)-derived L3 Skeletal Muscle Index (L3 SMI) may overlook localized muscle loss and be confounded by fluid shifts. Point-of-care ultrasound (POCUS) offers a bedside, repeatable method for assessing peripheral muscle thickness. Objectives: To determine the prognostic value of peripheral muscle thickness, measured by POCUS, in predicting mortality, frailty, and functional outcomes in critically ill patients; and to compare these findings with core muscle mass assessed by L3 SMI. Design: Prospective, single-center, observational study of critically ill adults admitted to the ICU with sepsis or requiring organ support. Methods: Fifty critically ill adults meeting Sepsis-3 criteria or requiring respiratory/vasopressor support underwent POCUS assessments of biceps brachii, rectus femoris, and vastus intermedius thickness at days 1, 7, and 14 post-ICU admission. Twenty-eight patients also had CT scans within 7 days for L3 SMI calculation. The primary outcome was in-hospital mortality; secondary outcomes included Clinical Frailty Score and Zubrod/ECOG performance status, 90-day mortality and hospital readmission, and number of organ dysfunction-free days. Muscle measurements were analyzed both raw and indexed to body surface area, with predictive performance assessed via correlation and receiver operating characteristic analysis. Results: Day 1 biceps brachii thickness strongly predicted in-hospital mortality (area under the curve [AUC] 0.84; sensitivity 1.0, specificity 0.67) and retained predictive value for 30-day and 90-day mortality. Vastus intermedius thickness on Day 1 was moderately predictive (AUC 0.79). At later time points, larger vastus intermedius measurements correlated negatively with ICU- and ventilator-free days, suggesting edema-related pseudohypertrophy. L3 SMI did not significantly correlate with ultrasound-based muscle measurements or clinical outcomes. POCUS-derived peripheral muscle indexing was associated with frailty indices, highlighting its role in capturing meaningful functional deficits. Conclusion: POCUS-based muscle assessments, particularly of the biceps brachii and vastus intermedius, provide valuable prognostic insights beyond conventional L3 SMI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.